A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids.

Ralph Mosges Christoph Zeyen Esther Raskopf Cengizhan Acikel Hacer Sahin Silke AllekotteMandy CuevasM H Mohamed Shamji José Luis Subiza Miguel Casanovas

Published in: Allergy (2023)

All doses of mannan-conjugated birch pollen allergoids can be considered as safe. Since the application of 10,000 mTU/mL resulted in the highest efficacy, this dose qualifies for further investigation.

Keyphrases

double blind
photodynamic therapy
placebo controlled
clinical trial
study protocol
phase iii
phase ii
open label